Nagarjuna Reddy Cheemarla

Dr. Nagarjuna Reddy Cheemarla


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 September 2023 in The Journal of Infectious Diseases
Verified
Journal Article
Closed access
PDF file
NCNagarjuna Reddy Cheemarla
Nagarjuna Reddy Cheemarla
TWTimothy A Watkins
Timothy A Watkins
VMValia T Mihaylova
Valia T Mihaylova
EFEllen F Foxman
Ellen F Foxman
To gain insight into interactions among respiratory viruses, we modeled influenza A virus (IAV)-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) coinfections using differentiated human airway epithelial cultures. Replicating IAV induced a more robust interferon response than SARS-CoV-2 and suppressed SARS-CoV-2 replication in both sequential and simultaneous infections, whereas SARS-CoV-2 did not enhance host cell defense during influenza infection or suppress IAV replication. Oseltamivir, an antiviral targeting influenza, reduced IAV replication during coinfection but also reduced the host antiviral response and restored SARS-CoV-2 replication. These results demonstrate how perturbations in one viral infection can impact its effect on a coinfecting virus.

21 October 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
IMIván Martínez-Espinoza
Iván Martínez-Espinoza
PBPius I Babawale
Pius I Babawale
HMHannah Miletello
Hannah Miletello
NCNagarjuna Reddy Cheemarla
Nagarjuna Reddy Cheemarla
AGAntonieta Guerrero-Plata
Antonieta Guerrero-Plata
Background: Interferon epsilon (IFN-ε) is a type I IFN that plays a critical role in the host immune response against pathogens. Despite having demonstrated antiviral activity in macrophages and mucosal tissues such as the female reproductive tract and the constitutive expression in mucosal tissues such as the lung, the relevance of IFN-ε against respiratory viral infections remains elusive. Results: We present, for the first time, the expression of IFN-ε in alveolar epithelial cells and primary human bronchial epithelial cells grown in an air–liquid interface (ALI) in response to human metapneumovirus (HMPV) and respiratory syncytial virus (RSV) infection. The molecular characterization of the IFN-ε induction by the viruses indicates that the expression of RIG-I is necessary for an optimal IFN-ε expression. Furthermore, treatment of the airway epithelial cells with rhIFN-ε induced the expression of IFN-stimulated genes (ISGs) and significantly restricted the viral replication of HMPV and RSV. Conclusions: These findings underscore the relevance of IFN-ε against viral infections in the respiratory tract.